Clinical Research Demo Pharmaceuticals 
H1 Blog
JULY 30, 2024
The recent draft by the FDA introduces additional guidelines for Diversity Action Plans aimed at improving diversity in clinical research. Hence, pharmaceutical companies need to start making preparations to ensure compliance with the new requirements. Find out more by requesting a demo today.
H1 Blog
MAY 4, 2023
Insights for Thought Leading Stakeholder Engagement to Decrease Medication Non-Adherence Pharmaceutical companies have long recognized the importance of engaging key opinion leaders (KOLs) to gain insight and support for clinical research, drug development, and medical education.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
H1 Blog
DECEMBER 18, 2023
Every year, we take a look at annual predictions to help life sciences, pharmaceutical, and healthcare companies understand larger industry trends and dynamics to prepare for the new year. These forecasts, curated by our own experts and thought leaders, shed light on the changes set to reshape the healthcare and pharmaceutical sectors.
Vial
JUNE 24, 2024
The fields of artificial intelligence (AI) and machine learning (ML) are increasingly influencing clinical research and development (R&D). Contract research organizations (CROs) and pharmaceutical companies can leverage these cutting-edge technologies to streamline clinical trials and introduce automation in drug discovery.
H1 Blog
NOVEMBER 29, 2023
The initial report, which came out In 2013 from PhRMA/EFPIA, recognized the importance of data sharing and supported initiatives to enhance clinical trial data transparency and promote scientific advancements. Case Study: Equitable Clinical Trial Access for Women, Minorities Among Cardiovascular Disease in the U.S.
Expert insights. Personalized for you.
59 
Let's personalize your content